Results 221 to 230 of about 13,693,576 (308)

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin   +11 more
wiley   +1 more source

Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the test performance of cutaneous phosphorylated alpha‐synuclein (P‐SYN) in dementia with Lewy bodies (DLB), individuals with reduced Montreal Cognitive Assessment (MoCA) and healthy controls. Methods This is the first subgroup analysis of the Synuclein‐One study, a prospective, blinded study evaluating P‐SYN detection ...
Christopher H. Gibbons   +31 more
wiley   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein   +13 more
wiley   +1 more source

Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt   +5 more
wiley   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Uncertainty measure in evidence theory

Science China Information Sciences, 2020
Yong Deng
semanticscholar   +3 more sources

Quantum X-entropy in generalized quantum evidence theory

Information Sciences, 2023
In this paper, a new quantum model of generalized quantum evidence theory is proposed. Besides, a new quantum X-entropy is proposed to measure the uncertainty in generalized quantum evidence theory.
Fuyuan Xiao
semanticscholar   +1 more source

Plausibility Entropy: A New Total Uncertainty Measure in Evidence Theory Based on Plausibility Function

IEEE Transactions on Systems, Man, and Cybernetics: Systems, 2023
Evidence theory provides an effective representation and handling framework for uncertain information. However, the quantification for the uncertainty of mass function in this theory is still an unsolved problem.
Yebi Cui, Xinyang Deng
semanticscholar   +1 more source

A new complex evidence theory

Information Sciences, 2022
Dempster-Shafer evidence theory, as an extension of Probability theory, is widely used in the field of information fusion due to it satisfies weaker conditions than probability theory in dealing with uncertain information.
Lipeng Pan, Yong Deng
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy